OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Tamir Sholklapper, Michael Creswell, Alexandra T. Payne, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Tamir Sholklapper, Michael Creswell, Alexandra T. Payne, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Showing 6 citing articles:
Screening for Financial Toxicity Among Patients With Cancer: A Systematic Review
Nadia L. Samaha, Leila J. Mady, Maria Armache, et al.
Journal of the American College of Radiology (2024) Vol. 21, Iss. 9, pp. 1380-1397
Closed Access | Times Cited: 5
Nadia L. Samaha, Leila J. Mady, Maria Armache, et al.
Journal of the American College of Radiology (2024) Vol. 21, Iss. 9, pp. 1380-1397
Closed Access | Times Cited: 5
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy
Min Jung Koh, Min Ji Koh, Jessica Hsueh, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Min Jung Koh, Min Ji Koh, Jessica Hsueh, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Social Needs in Cancer Survivors: A Scoping Review and Future Directions
Tess Thompson, Meredith Doherty, Julie Berrett‐Abebe, et al.
Current Oncology Reports (2025)
Closed Access
Tess Thompson, Meredith Doherty, Julie Berrett‐Abebe, et al.
Current Oncology Reports (2025)
Closed Access
Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists
Victoria S. Wu, Xinglei Shen, Janet S. de Moor, et al.
Advances in Radiation Oncology (2023) Vol. 9, Iss. 3, pp. 101419-101419
Open Access | Times Cited: 8
Victoria S. Wu, Xinglei Shen, Janet S. de Moor, et al.
Advances in Radiation Oncology (2023) Vol. 9, Iss. 3, pp. 101419-101419
Open Access | Times Cited: 8
Assessment of the prevalence and related factors of financial toxicity in cancer patients based on the COST scale: A systematic review and meta-analysis
Shuping Wang, Jialin Wang, Hua Kang, et al.
European Journal of Oncology Nursing (2023) Vol. 68, pp. 102489-102489
Closed Access | Times Cited: 6
Shuping Wang, Jialin Wang, Hua Kang, et al.
European Journal of Oncology Nursing (2023) Vol. 68, pp. 102489-102489
Closed Access | Times Cited: 6
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer
Lindsey Gallagher, Jerry Xiao, Jessica Hsueh, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Lindsey Gallagher, Jerry Xiao, Jessica Hsueh, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations
P. Travis Courtney, Luca Valle, Ann C. Raldow, et al.
Seminars in Radiation Oncology (2023) Vol. 34, Iss. 1, pp. 4-13
Closed Access | Times Cited: 4
P. Travis Courtney, Luca Valle, Ann C. Raldow, et al.
Seminars in Radiation Oncology (2023) Vol. 34, Iss. 1, pp. 4-13
Closed Access | Times Cited: 4
